Literature DB >> 4589814

Development of reticulum cell sarcoma during cyclophosphamide therapy.

H Tannenbaum, P H Schur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4589814     DOI: 10.1002/art.1780170104

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  7 in total

1.  Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease.

Authors:  R R Love; J M Sowa
Journal:  Ann Rheum Dis       Date:  1975-12       Impact factor: 19.103

2.  Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up.

Authors:  A A Drosos; D Psychos; A P Andonopoulos; S Stefanaki-Nikou; E B Tsianos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 3.  Problems with immunosuppressive agents in renal disease.

Authors:  J S Cameron
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

4.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 5.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

6.  Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.

Authors:  J S Cameron; C Chantler; C S Ogg; R H White
Journal:  Br Med J       Date:  1974-10-05

7.  Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.

Authors:  H L Currey; J Harris; R M Mason; J Woodland; T Beveridge; C J Roberts; D W Vere; A S Dixon; J Davies; B Owen-Smith
Journal:  Br Med J       Date:  1974-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.